Anagrelide for essential thrombocythemia.

D. Green
DOI: https://doi.org/10.1056/OH201301220000001
2013-01-22
Abstract:Anagrelide, a selective platelet-lowering agent, was introduced more than a decade ago for the treatment of essential thrombocythemia (ET). However, in
What problem does this paper attempt to address?